Sacroplasty for sacral insufficiency fractures  by Hassan, Mohamed Sobhi
The Egyptian Journal of Radiology and Nuclear Medicine (2015) 46, 987–991Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLESacroplasty for sacral insuﬃciency fracturesAbbreviations: VRNS, verbal numeric rating scale; PMMA, poly
(methyl methacrylate); ECOG, Eastern Cooperative Oncology Group;
SIF, sacral insufﬁciency fracture; NSAID, non-steroidal anti-
inﬂammatory drugs
* Address: Flat No. 6, 104 Abbas El-Akkad St., Nasr City, Cairo,
Egypt. Tel.: +20 1001572843.
E-mail address: mohincanada@yahoo.com
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2015.06.003
0378-603X  2015 The Author. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Mohamed Sobhi Hassan *Radiology Department, Ain Shams University, Cairo, EgyptReceived 25 February 2015; accepted 5 June 2015
Available online 11 July 2015KEYWORDS
Sacral insufﬁciency fracture;
Sacroplasty;
Back painAbstract Background: Pelvic insufﬁciency fractures are an overlooked cause of back pain in
elderly. Aim of the study: To evaluate the efﬁcacy and safety of sacroplasty as a management of
sacral insufﬁciency fractures. Patients and method: This study included 8 patients suffering from sev-
ere lower back pain due to sacral insufﬁciency fracture. Sacroplasty was done under ﬂuoroscopy
and CT guidance. Pain before and after the procedure was assessed by verbal numeric rating scale
and also the performance status was assessed using the Eastern Cooperative Oncology Group score.
Results: All the patients reported decreased pain score with a mean of 5.625. 7 Patients showed
improved performance status and one patient remained the same. In only one case we had leakage
within the soft tissue of pelvis anteriorly that did not have clinical consequences. Conclusion:
Sacroplasy is an effective and safe method to decrease pain resulting from sacral insufﬁciency frac-
tures. It also improves performance status of patients. Dual guidance by CT and ﬂuoroscopy is the
best choice for proper and safe technique.
 2015 The Author. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sacral insufﬁciency fractures are usually overlooked in the
elderly and other risk group of structurally weakened bone
with low back and pelvic pain following no or trivial trauma
(1,2). The precise incidence of the sacral insufﬁciency fracture
is unknown. However, the potential prevalence of sacral insuf-
ﬁciency fracture (SIF) is considered to be higher than thewidely appreciated and sacral insufﬁciency fractures are
remained largely overlooked causes of pain and disability
within the elderly and other risk population (3).
Vertebroplasty is a technique of injecting polymethyl-
methacrylate (PMMA) cement into a vertebral compression
fracture for pain relief and support. If these techniques could
be applied to sacral insufﬁciency fractures, patients might gain
some pain relief. In this study 8 elderly patients presented with
acute back pain due to sacral insufﬁciency fractures were man-
aged by sacroplasty and the outcome as regards pain relief and
any resultant complications were studied.
2. Patients and method
The study began at August 2012 and ended at December 2013.
Study was done in Ain Shams Specialized Hospital. This study
included 8 patients suffering from severe lower back pain due
Table 1 Pain and pain medications before and after sacroplasty.
Patients Pre-procedure pain score Post-procedure pain score Improvement of pain Pre-procedure pain
medication type
Post-procedure pain
medication type
1 9 3 6 Opiates NSAID
2 10 2 8 Opiates –
3 7 4 3 NASID –
4 9 4 5 Opiates Opiates
5 10 1 9 Opiates Opiates
6 8 2 6 Opiates NSAID
7 9 5 4 NSAID NSAID
8 10 6 4 Opiates NSAID
Table 2 Performance status before and after sacroplasty.
Patients Performance status before
the procedure
Performance status after
the procedure
1 3 1
2 3 1
3 2 2
4 3 2
5 2 0
6 3 1
7 3 2
8 3 2
988 M.S. Hassanto sacral insufﬁciency fracture. Patients with metastatic lesions
were excluded (see Tables 1 and 2).
All of the patients had CT and MRI and all of them were
referred to our department after failure of conservative man-
agement to control pain. Pain before and after the procedure
was assessed by verbal numeric rating scale (VNRS) and also
the performance status was assessed using the Eastern
Cooperative Oncology Group (ECOG) score. Neurological
examination was done by a neurologist to document any
deﬁcit (see Fig. 1).
3. Technique
The patient was placed in prone position on CT table (soma-
tom deﬁnition ﬂash) and procedure was done under consciousFig. 1 Pain score by verbal numeric rating scale (VNRS) before
and after sacroplasty. In our patients 7 reported signiﬁcant relief
of pain and only one patient reported slight improvement with
none of the patients reporting increased pain. Average improve-
ment of pain was 5.625.sedation. The entire patient received 1 g of Cefotaxime before
the procedure.
A CT sequence was taken of the sacral region to localize the
vertical fracture lines of the H shaped sacral insufﬁciency frac-
tures (Figs. 3A, B and 4A, B). The level of the placement of
the needle was selected at the upper part of fracture lines
within the ala on each side (Fig. 3F and G). A 13 gauge
beveled bone biopsy needle was placed in each side within
the fracture line in oblique craniocaudal orientation in order
to seal the fracture line with the cement. The bevel of the nee-
dle was directed laterally to prevent cement from ﬂowing
towards the sacral foramina.
Patient was then transferred to our angiography suit (Artis
zee biplane) and polymethylmethacrylate (PMMA) was pre-
pared. We mixed the powder with less polymer to keep the
cement in a pasty consistency to prevent ﬂow into the sacral
foramina, yet not too thick so that it can ﬂow along the frac-
ture lines (Figs. 3H, I, and 4E).
Repeated Switching of the tube from anteroposterior to lat-
eral views was done during injection of cement and stoppage of
injection was done if cement ﬂows medially in anteroposterior
view or anteriorly in lateral view. Postoperative CT was done
only if leakage to sacral canal or foramina was suspected
(Fig. 4F and G).
4. Results
This study included 8 patients suffering from severe lower back
pain due to sacral insufﬁciency fracture. Patients were 6
females and 2 males with a mean age of 77. Only 5 patients
had history of trauma and all were in the form of falling down
during household activities, the other 3 patients had noFig. 2 Performance status before and after the procedure.
Fig. 3 (A and B) Axial CT cuts showing sacral insufﬁciency fracture line at right sacral ala. (B) Axial FSE, (C) axial T1 and (D) coronal
FSE showing the fracture on the right side and also oedema at left ala especially seen in axial T1. (F and G) CT guided placement of
needles within the fracture line on the right side and at left sacral ala. (H and I) Injection of cement under ﬂuoroscopy.
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Fig. 4 (A and B) Axial CT images showing a sacral insufﬁciency fracture of right ala. (C and D) Coronal T1 images showing the fracture
on the right side and oedema on both sides. (E) Fluoroscopy image during injection of cement. (F and G) Axial CT images after
sacroplasty showing leakage of cement into the soft tissue of pelvis on the right side.
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ture to.
All patients received treatment for both sides. The amount
injected on each side had an average of 2.5 cc with a total of
5 mm for both sides. No patient had leakage within the sacral
foramina or within the sacral canal. Only one patient had leak-
age into the soft tissue of pelvis anteriorly with no clinical
consequences.
Before the procedure 6 patients received opiates to control
their pain and for the other 2 NSAID were sufﬁcient for pain
control. After the procedure 2 patients stopped the pain med-
ications (one was on NASID and the other was on opiates). 3
patients shifted from opiates to NSAID. 3 patients remained
on same type of pain management, 2 were on opiates and 1
was on NSAID; however those patients also reported
decreased doses.
The sacroplasty also improved the performance status of 7
patients (3 improved by one degree and 4 improved by 2
degrees). One patient who had a performance status of 2
remained the same.
5. Discussion
In our study all the patients had improved VAS of pain with a
mean of 5.625. Our study included a limited number of
patients. In a similar study by Strub et al. in 2007 (4) including
13 patients, only one of them did not have any improvement
after sacroplasty. Another earlier case report of only three
cases was published by Pommersheim in 2003 (5) who reported
improvement in all 3 cases. The limited number of these cases
questioned the real value of sacroplasty and a study including
a larger number of patients was needed to verify the previous
study results, but the difﬁculty of diagnosing sacral insufﬁ-
ciency fractures yielded this low number of patients in single
centre studies. However multicentred study was published by
Kortman et al. in 2013 (6) that included 240 patients reported
increased pain as assessed by VAS from 9.2 ± 1.1 before
sacroplasty to 1.9 ± 1.7 after sacroplasty. Our study also
looked at decreased need for pain medications and not only
VAS and this also has decreased conﬁrming the good response
of pain controlling effect of sacroplasty.
Immobility following sacral insufﬁciency fractures can lead
to DVT, decubitus ulcers, chest infection and even depression,
so early ambulation after sacroplasty and not only pain con-
trol does matter. 7 of our patients had improved performance
status after sacroplasty and the one patient who did not
improve was already ambulatory. This was also reported by
another study of sacroplasty for myeloma by Basile et al. in
2010 (7) which included 8 patients and all had improved per-
formance status after sacroplasty.
Although sacroplasty can be done guided by ﬂuoroscopy
alone, it’s technically challenging as its difﬁcult to know
whether the tip of the needle had traversed the outer cortex
and did not traverse the inner cortex to pelvic cavity (5).Using CT on the other hand can facilitate precise placement
of needle tip within the fracture lines, yet ﬂuoroscopy remains
better for watching for leakage during cement injection (5).
Dual guidance using CT and Fluoroscopy whether in the same
theatre or by transmitting the patient to ﬂuoroscopy suit as we
did is the method of choice because it allows for proper place-
ment of needles by CT and early detection of any leakage using
ﬂuoroscopy.
Complications of sacroplasty can result from leakage of
cement outside the cancellous bone of sacrum and especially
into the sacral foramina. Careful slow injection under ﬂuo-
roscopy prevents signiﬁcant leakage. We only had one case
of leakage into the anterior soft tissue of sacrum that was con-
ﬁrmed by CT and did not have any clinical consequences
(Fig. 2f and g). Previous studies conﬁrm the safety of sacro-
plasty. In the multicentre study of Kortman et al. in 2013 (6)
only one case had a leakage that necessitated surgical interfer-
ence in the form of decompression of a compressed root.
6. Conclusion
Sacroplasy is an effective and safe method to decrease pain
resulting from sacral insufﬁciency fractures. It also improves
performance status of patients. Dual guidance by CT and ﬂu-
oroscopy is the best choice for proper and safe technique.
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